TVARDI THERAPEUTICS, INC. Temporary Equity, Elimination as Part of Reorganization
TVARDI THERAPEUTICS, INC. (TVRD) reported Temporary Equity, Elimination as Part of Reorganization of $85.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityEliminationAsPartofReorganization · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. temporary equity, elimination as part of reorganization for the quarter ending 2025-06-30 was $85.50M.
- TVARDI THERAPEUTICS, INC. temporary equity, elimination as part of reorganization for fiscal 2025 was $85.50M.
| Period end | Temporary Equity, Elimination as Part of Reorganization 3 month | Temporary Equity, Elimination as Part of Reorganization 12 month |
|---|---|---|
| 2025-12-31 | $85.50M 10-K · filed 2026-03-31 | |
| 2025-06-30 | $85.50M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |